A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients

NCT01745094 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: mirabegron
DRUG: solifenacin

Sponsor

Astellas Pharma Inc